The poisoned child in the pediatric intensive care unit

Usama A Hanhan1

  • 1Division of Pediatrics, Department of Critical Care Medicine, University Community Hospital, 3100 East Flecher Ave., Tampa, FL 33613, USA. uhanhan@uch.mail.org

Insights

Pediatric poisoning management has evolved, with gastric decontamination techniques abandoned due to risks and lack of evidence. Supportive care is now the primary treatment for poisoned children.

Area of Science:

  • Pediatric Emergency Medicine
  • Toxicology
  • Clinical Pediatrics

Background:

  • Acute poisoning in children presents a significant challenge for pediatricians globally.
  • Management strategies for pediatric poisoning have undergone substantial evolution over time.
  • Traditional methods like gastric decontamination are increasingly questioned.

Purpose of the Study:

  • To review the current landscape of pediatric poisoning management.
  • To highlight the shift away from historical decontamination techniques.
  • To emphasize the importance of supportive care in acute pediatric poisoning.

Main Methods:

  • Review of current literature and clinical practices in pediatric toxicology.
  • Analysis of the evidence supporting or refuting gastric decontamination methods.
  • Evaluation of the role of supportive care, antidotes, and specific interventions.

Main Results:

  • Gastric decontamination methods have largely fallen out of favor due to insufficient evidence of benefit and significant risks.
  • Supportive care remains the cornerstone of managing acute poisoning in children.
  • Antidotes and specific interventions are beneficial only in a limited number of cases.

Conclusions:

  • Modern pediatric poisoning management prioritizes supportive care over aggressive decontamination.
  • Clinicians should critically evaluate the risks versus benefits of any intervention in poisoned children.
  • Evidence-based practice is crucial in refining the care of acutely poisoned pediatric patients.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...